30 Participants Needed

GyroGlove for Essential Tremor

Recruiting at 6 trial locations
FO
Overseen ByFaii Ong

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests the GyroGlove, a special glove that helps reduce hand tremors using gyroscopes. It targets people with hand tremors who may not respond well to other treatments.

Do I need to stop my current medications for the trial?

The trial requires that you keep a stable dosage of your current medications throughout the study, if applicable. This means you should not change your medication dosage during the trial.

How is the GyroGlove treatment different from other treatments for essential tremor?

The GyroGlove is unique because it is a wearable device designed to stabilize hand tremors using gyroscopic technology, unlike other treatments that involve medication or invasive surgical procedures like deep brain stimulation or radiosurgery.12345

Who Is on the Research Team?

RW

Richard Walker

Principal Investigator

North Tyneside General Hospital

Are You a Good Fit for This Trial?

This trial is for adults over 18 with Essential Tremor (ET) who can follow instructions and have a stable medication dosage. They must experience hand tremors that cause spills when drinking, but not be pregnant, use certain substances, or have conditions like Parkinson's disease or implanted electrical devices.

Inclusion Criteria

I have been diagnosed with essential thrombocythemia (ET).
I experience shaking in one or both of my hands or mostly in my hands and forearms.
I spill water because of hand tremors when I drink.
See 6 more

Exclusion Criteria

Clinically diagnosed alcohol use disorder or illicit substance use (exception medical cannabis)
I haven't changed my tremor medication in the last month.
I have tremors in my arm that make it hard to do certain tasks.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Baseline Assessment

Participants perform protocol-specific activities with both investigational devices (GyroGlove and Placebo) in a blinded sequence

1 day
1 visit (in-person)

Treatment

Participants use the GyroGlove at home and complete self-assessments

2 weeks
Self-assessments on Day -3, Day 5, and Day 10

Follow-up

Participants are monitored for safety and effectiveness after treatment

1 day
1 visit (in-person)

Open-label Extension

Participants receive the GyroGlove for two weeks during the open label follow up part of the trial

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • GyroGlove
Trial Overview The GyroGlove is being tested against a placebo in people with ET. Participants will first try the glove for two weeks to see if it helps control their tremors. The study design includes an initial assessment followed by this open label period where everyone gets the real glove.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Investigational Device ArmExperimental Treatment1 Intervention
Group II: No InterventionalActive Control1 Intervention
Group III: Placebo ArmPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

GyroGear Ltd

Lead Sponsor

Trials
1
Recruited
30+

Citations

DBS, tcMRgFUS, and gamma knife radiosurgery for the treatment of essential tremor: a systematic review on techniques, indications, and current applications. [2022]
The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models. [2022]
A case report of complete disappearance of essential tremor after Gamma Knife radiosurgery. [2004]
Stereotactic radiosurgery for essential tremor: Retrospective analysis of a 19-year experience. [2018]
[Essential tremor]. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security